Medisinsk forskning på cannabis
I dette arkivet finner du over 15 000 lenker til forskningsartikler og studier på cannabis planten. Listen er på engelsk, delt opp i medisinske lidelser og andre kategorier i alfabetisk rekkefølge.
NB! Sidene på hver bokstav kan laste tregt da tusenvis av linker lastes
I
IBS/IBD (86)
-
Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
-
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease
-
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents
-
Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients with Non-Constipated Irritable Bowel Syndrome
-
Cannabis use amongst patients with inflammatory bowel disease
-
Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study
-
Role of cannabinoid receptors and RAGE in inflammatory bowel disease
-
Irritable bowel syndrome: a dysfunction of the endocannabinoid system?
-
The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility
-
Genetic Epidemiology and Pharmacogenetics in Irritable Bowel Syndrome
-
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome
-
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea
-
Gut microbiota and the development of obesity
-
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity
-
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
-
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity
-
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
-
Agents that act luminally to treat diarrhoea and constipation
-
Cannabis Finds Its Way into Treatment of Crohnâs Disease
-
Role of endogenous cannabinoid system in the gut
-
Irritable Bowel Syndrome and Migraine: Bystanders or Partners?
-
Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study
-
Cannabinoid Receptor 1 Gene and Irritable Bowel Syndrome: Phenotype and Quantitative Traits
-
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis
-
Marijuana use patterns among patients with inflammatory bowel disease
-
Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study
-
Industrial hemp decreases intestinal motility stronger than indian hemp in mice
-
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
-
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system
-
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system
-
Cannabidiol in inflammatory bowel diseases: a brief overview
-
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model
-
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract
-
Decreased Enteric Fatty Acid Amide Hydrolase Activity is Associated with Colonic Inertia in Slow Transit Constipation
-
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System
-
Genetic polymorphism in pathogenesis of irritable bowel syndrome
-
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders
-
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal antiinflammatory agent
-
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors
-
Endocannabinoid signalling and the deteriorating brain
-
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides
-
Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not âhigherâ
-
Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1
-
Medical Marijuana for Digestive Disorders: High Time to Prescribe?
-
Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice
-
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon Npalmitoylethanolamine levels and counteracts murine colitis
-
Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome
-
Switching cannabinoid response from CB2 agonists to FAAH inhibitors
-
Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats
-
The endocannabinoid anandamide regulates the peristaltic reflex by reducing neuro-neuronal and neuro-muscular neurotransmission in ascending myenteric reflex pathways in rats
-
Cannabis for inflammatory bowel disease
-
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Î9-tetrahydrocannabinol pharmacology
-
Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
-
Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome
-
No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects
-
Pharmacogenetics in irritable bowel syndrome
-
Monoglyceride lipase-deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity
-
A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway
-
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner
-
In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat
-
Cannabinoids Regulate Intestinal Motor Function and Electrophysiological Activity of Myocytes in Rodents
-
Cannabis â therapy for the future?
-
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease
-
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population-based analysis
-
Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes
-
Endocannabinoids in the Gut
-
The CB2 receptor and its role as a regulator of inflammation
-
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK
-
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse
-
Therapeutic Use of Cannabis in Inflammatory Bowel Disease
-
The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments
-
Getting into the weed: the role of the endocannabinoid system in the brain-gut axis
-
Medical use of cannabis products : Lessons to be learned from Israel and Canada
-
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review
-
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives
-
The gastrointestinal tract â a central organ of cannabinoid signaling in health and disease
-
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High
-
Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23âIL-17 signalling in macrophages
-
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review
-
Cannabinoids and GI Disorders: Endogenous and Exogenous
-
Role of cannabis in digestive disorders
-
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohnâs Disease and Ulcerative Colitis
-
Medical Cannabis â another piece in the mosaic of autoimmunity?
-
Role of cannabis in digestive disorders
IMMUNE SYSTEM (162)
-
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
-
Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity
-
Do cannabinoids have a therapeutic role in transplantation?
-
Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS
-
Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties
-
Cannabinoids and Viral Infections
-
Cannabinoids and the immune system: an overview
-
Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol
-
New blood brothers: the GPR55 and CB2 partnership
-
Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS
-
Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura
-
Cannabinoid Receptor 2 Is Critical for the Homing and Retention of Marginal Zone B Lineage Cells and for Efficient T-Independent Immune Responses
-
Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection
-
Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells
-
Modulation of the novel cannabinoid receptor â GPR55 â during rat fetoplacental development
-
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation
-
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
-
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells
-
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis
-
Cannabis use and Cognitive Function: Eight Year Trajectory in a Young Adult Cohort
-
Cannabinoids and sepsis
-
Dynamic changes to the endocannabinoid system in models of chronic pain
-
Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Upregulation of Serum IgE Levels in Immunized Mice
-
Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids
-
Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntingtonâs Disease
-
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide
-
Endocannabinoid modulation of jejunal afferent responses to LPS
-
Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis
-
The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease
-
Cannabinoid receptor-2-selective agonists improve recovery in experimental autoimmune encephalomyelitis
-
Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation
-
Immunity and early pregnancy events: are endocannabinoids the missing link?
-
Î9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2
-
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120
-
Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice
-
Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Î9-Tetrahydrocannabinol in vivo: Regulation of CCAAT/enhancer binding protein alpha by microRNA-690
-
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immuno-suppressive properties
-
Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens
-
2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release anti-microbial effectors against E. coli, S. aureus, HSV-1, and RSV
-
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death
-
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis
-
Î9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2
-
Multiple sclerosis and the blood-central nervous system barrier
-
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation
-
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
-
Cannabinoid (CB)1 receptors are critical for the innate immune response to TLR4 stimulation
-
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling
-
Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction
-
Cannabinoid receptor modulation of the endothelial cell inflammatory response
-
Cytokine release in sepsis
-
Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells
-
Targeting the Endocannabinoid System to Treat Sepsis
-
Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic child-hood immune thrombocytopenia in Egypt
-
Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma
-
Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome
-
G-protein coupled receptor 18 (GPR18) in channel catfish: expression analysis and efficacy as immunostimulant against Aeromonas hydrophila infection
-
Cannabinoids decrease the th17 inflammatory autoimmune phenotype
-
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
-
Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections
-
Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction
-
Polyunsaturated Fatty Acid-Derived Lipid Mediators and T Cell Function
-
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis
-
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages
-
The expression of cannabinoid receptor 1 is significantly increased in atopic patients
-
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
-
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis
-
Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion
-
Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1
-
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins
-
Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation
-
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells
-
Histone modifications are associated with Î9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses
-
What we know and do not know about the cannabinoid receptor 2 (CB2)
-
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease
-
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters
-
Inhaled medicinal cannabis and the immunocompromised patient
-
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases
-
CANNABINOIDS INCREASE LUNG CANCER CELL LYSIS BY LYMPHOKINE-ACTIVATED KILLER CELLS VIA UPREGULATION OF ICAM-1
-
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases
-
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination
-
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
-
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells
-
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells
-
Endocannabinoid signaling in innate and adaptive immunity
-
Endocannabinoid signaling in innate and adaptive immunity
-
Pathogenesis of Systemic Sclerosis
-
Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA
-
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis
-
Expression Analysis of CB2-GFP BAC Transgenic Mice
-
Cannabis â the Israeli perspective
-
Restoring homeostasis of CD4(+) T cells in hepatitis-B-virus-related liver fibrosis
-
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
-
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice
-
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials
-
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis
-
Î9 Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived cell activation via STAT3/S100A8
-
Effects of Cannabinoids on T-cell Function and Resistance to Infection
-
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoylglycerol and arachidonoyl-ethanolamide, and their metabolites
-
Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo
-
A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10
-
Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption
-
Î9-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells
-
Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell Activation
-
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
-
The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA)
-
The cannabinoid receptor 2 is involved in acute rejection of cardiac allografts
-
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
-
The endocannabinoid system and its therapeutic implications in rheumatoid arthritis
-
Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Î9-Tetrahydrocannabinol
-
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity
-
Downstream effects of endocannabinoid on blood cells: implications for health and disease
-
Pro-inflammatory obesity in aged cannabinoid-2 receptor deficient mice
-
Cannabinoid receptor 1 but not 2 mediates macrophage phagocytosis by G(α)i/o /RhoA/ROCK signaling pathway
-
Endocannabinoids and the Immune System in Health and Disease
-
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis
-
Combined effects of HIV and marijuana use on neurocognitive functioning and immune status
-
Dietary Carbohydrates that Modulate the Immune System
-
Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model
-
Lipid signaling in adipose tissue: Connecting inflammation & metabolism
-
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model
-
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2
-
Endocannabinoids as Guardians of Metastasis
-
A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine Model
-
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
-
Acetaminophen Attenuates House Dust Mite Induced Allergic Airway Disease in Mice
-
Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation.
-
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
-
The CB2 receptor and its role as a regulator of inflammation
-
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinsonâs disease
-
Longitudinal examination of the intestinal lamina propria cellular compartment of SIVinfected rhesus macaques provides broader and deeper insights into the link between aberrant microRNA expression and persistent immune activation
-
Effects of Different Levels of Hemp Seed (Cannabis Sativa L.) and Dextran Oligosaccharide on Growth Performance and Antibody Titer Response of Broiler Chickens
-
Synthetic Cannabinoid-Induced Immunosuppression Augments Cerebellar Dysfunction in Tetanus-Toxin Treated Mice
-
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation. (click âMolecular Medicineâ for
-
Anti-N-methyl-D-aspartate receptor encephalitis and drug abuse â the probable role of molecular mimicry or the overstimulation of CB receptors in a 17-year-old adolescent â case report
-
Structure of Protein That Guides the Immune System Uncovered
-
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions.
-
Cannabinoids and autoimmune diseases: A systematic review
-
Marijuana-derived Î-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation
-
Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed type hypersensitivity
-
No significant effect of cannabis use on the count and percentage of circulating CD4 Tcells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort)
-
Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis
-
Chronic Î9-Tetrahydrocannabinol Administration Reduces IgE+B Cells but Unlikely Enhances Pathogenic SIVmac251 Infection in Male Rhesus Macaques of Chinese Origin
-
Expression analysis of cannabinoid receptors 1 and 2 in B cells during pregnancy and their role on cytokine production
-
Endocannabinoid system: a promising therapeutic target for the treatment of haematological malignancies?
-
Ethanol downregulates N-acyl phosphatidylethanolamine-phospholipase D expression in BV2 microglial cells via epigenetic mechanisms
-
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors
-
Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation
-
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response
-
Microglia activation states and cannabinoid system: Therapeutic implications
-
Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome
-
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors
-
Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes
-
Effect of marijuana use on thyroid function and autoimmunity
-
Medical Cannabis â another piece in the mosaic of autoimmunity?
-
Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation
-
CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma
-
Identification of an endocannabinoid system in the rat pars tuberalis-a possible interface in the hypothalamic-pituitary-adrenal system?
-
Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms
-
Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis
-
Serum endocannabinoids and N-acyl ethanolamines and the influence of simulated solar UVR exposure in humans in vivo
IMMUNE THROMBOCYTOPENIA (7)
-
Immune thrombocytopenia in children and adults: whatâs the same, whatâs different?
-
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura
-
Childhood immune thrombocytopenia-who will spontaneously recover?
-
Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt
-
2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts
-
Synthetic marijuana âK2â induced ITP
-
Distinctive effects of eicosapentaenoic and docosahexaenoic acids in regulating neural stem cell fate are mediated via endocannabinoid signalling pathways
INDICATIONS AND CLINICAL USES (29)
-
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant for administration by ingestion or other means (Health Canada)
-
âWho Are Medical Marijuana Patients? Population Characteristics from Nine California Assessment Clinicsâ
-
Cannabis and Its Derivatives: Review of Medical Use
-
An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California
-
Medical cannabis: the opportunity versus the temptation
-
Medical Marijuana: Clearing Away the Smoke
-
Therapeutic Potentials and uses of Cannabinoid Agonists in Health and Disease Conditions
-
The Therapeutic Potential of Cannabis and Cannabinoids
-
Marijuana: modern medical chimaera
-
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators
-
Cannabis Strain Explorer
-
Therapeutic potential of cannabinoid medicines
-
The pharmacologic and clinical effects of medical cannabis
-
Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use
-
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands
-
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample
-
Therapeutic benefits of cannabis: a patient survey
-
Medical marijuana: more questions than answers
-
Medical marijuana: more questions than answers
-
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis Extracts to Treat Diseases
-
Report on Medical Cannabis Research, What the Science Says
-
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical-Grade Cannabis
-
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders
-
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users
-
Plant derived substances with anti-cancer activity: from folklore to practice
-
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice
-
Medicinal cannabis
-
Evidence for Medicinal Use of Cannabis
-
Pros and cons of medical cannabis use by people with chronic brain disorders
INFANTS (46)
-
Use of dronabinol (delta-9-THC) in autism: A prospective single-case-study with an early infantile autistic child
-
The Maternal Lifestyle Study: Sleep Problems in Children with Prenatal Substance Exposure
-
The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia
-
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura
-
Examining the Health and Drug Exposures among Canadian Children Residing in Drug-Producing Homes
-
Prolonged coma in a child due to hashish ingestion with quantitation of THC metabolites in urine
-
Unresolved Discrepancies between Cannabinoid Test Results for Infant Urine
-
Acute cannabis poisoning in a 10-month-old infant
-
Cannabinoid modulation of mother-infant interaction: is it just about milk?
-
Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay.
-
The role of child protection in cannabis grow-operations
-
The consequences of pain in early life: injury-induced plasticity in developing pain pathways
-
Meconium Drug Testing in Multiple Births in the USA
-
Contribution of in utero drug exposure when interpreting hair results in young children
-
New horizons for newborn brain protection: enhancing endogenous neuroprotection
-
A cannabinoid-intoxicated child treated with dexmedetomidine: a case report
-
Unintentional Pediatric Exposure to a Synthetic Cannabinoid (AB-PINACA) Resulting in Coma and Intubation
-
Lipid mediator profile in vernix caseosa reflects skin barrier development
-
Perinatal asphyxia results in altered expression of the hippocampal acylethanolamide / endocannabinoid signaling system associated to memory impairments in postweaned rats
-
Prenatal exposure to recreational drugs affects global motion perception in preschool children
-
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes
-
Association between paracetamol use in infancy or childhood with body mass index
-
Use of paracetamol during pregnancy and child neurological development
-
Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor
-
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
-
Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report
-
Endocannabinoid Levels in Newborns in Relation to the Mode of Delivery
-
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro
-
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children
-
Maternal marijuana use and neonatal morbidity
-
Pharmacological Preventions of Brain Injury Following Experimental Germinal Matrix Hemorrhage: an Up-to-Date Review
-
Association between marijuana use and adverse obstetrical and neonatal outcomes
-
Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes
-
Sudden onset unexplained encephalopathy in infants: think of cannabis intoxication
-
Transient increase of interleukin-1β after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling
-
Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications
-
Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring
-
Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder
-
Detecting biomarkers of secondhand marijuana smoke in young children
-
Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation
-
Marijuana Use and Its Effects in Pregnancy
-
Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history
-
Neuroprotective Effects of Cannabidiol In Hypoxic Ischemic Insult: The Therapeutic Window In Newborn Mice
-
Cannabinoid Receptor 2 Activation Restricts Fibrosis and Alleviates Hydrocephalus after Intraventricular Hemorrhage
-
Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: A retrospective study at an academic medical center
-
Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity
INFLAMMATION (426)
-
Cannabinoid-induced apoptosis in immune cells as a pathway to immuno-suppression
-
Cannabinoids and Viral Infections
-
The endocannabinoid system as a target for the treatment of neurodegenerative disease
-
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
-
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation
-
Synthesis of Novel Cannabinoid Ligands and Their Use as Anti-Glioma and Anti-Inflammatory Agents
-
Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma
-
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor
-
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion
-
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice
-
European Patent Application EP2044935- A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases
-
WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice
-
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors
-
Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats
-
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study
-
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
-
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa
-
Gut feelings about the endocannabinoid system
-
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
-
Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents
-
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture
-
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death
-
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability
-
The Antinociceptive Effects of JWH-015 in Chronic Inflammatory Pain Are Produced by Nitric Oxide-cGMP-PKG-KATP Pathway Activation Mediated by Opioids
-
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation
-
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
-
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Î(9)-tetrahydrocannabinol in BV-2 microglial cells
-
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
-
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death
-
GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils
-
Resolution of inflammation by N-arachidonoylglycine
-
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ
-
Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection
-
US Patent 7884133 B2 Cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, antiinflammatory and antidiarrheal agents
-
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation
-
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation
-
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis
-
A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells
-
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells
-
Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells
-
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury
-
Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation
-
Prolonged oral Cannabinoid Administration prevents Neuroinflammation, lowers betaamyloid Levels and improves Cognitive Performance in Tg APP 2576 Mice
-
A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimerâs Disease
-
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation
-
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Non-inflammatory Pain
-
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α
-
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuro-inflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models
-
N-acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids â From fishy endocannabinoids to potential leads
-
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention?
-
Update on the role of cannabinoid receptors after ischemic stroke
-
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress
-
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α
-
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation
-
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions
-
Cannabinoid modulation of neuroinflammatory disorders
-
Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters â A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs
-
Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues
-
Review article: The endocannabinoid system in normal and pathological brain ageing
-
Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L.) and mice and induces weight gain and inflammation in mice
-
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
-
βâAmyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors
-
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice
-
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor
-
Differential Modulation by Delta(9)-Tetrahydrocannabinol (â (9)-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4(+) T cells
-
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?
-
Activation of Cannabinoid Receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms
-
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice
-
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
-
Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions
-
Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression
-
DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses
-
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis
-
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide
-
Endocannabinoids limit excessive mast cell maturation and activation in human skin
-
Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis
-
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
-
Pharmacological manipulation of cannabinoid neurotransmission reduces neuroinflammation associated with normal aging
-
Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice
-
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimerâs disease via regulation of β-secretase activity
-
The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease
-
Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain-gut axis
-
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke
-
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway
-
Cannabinoid receptor-2-selective agonists improve recovery in experimental autoimmune encephalomyelitis
-
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells
-
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat
-
Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice
-
Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation
-
Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats
-
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury
-
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
-
N-arachidonoyl glycine induces macrophage apoptosis via GPR18
-
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat
-
Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats
-
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation
-
Neuroprotective agents: cannabinoids
-
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology
-
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors
-
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway
-
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
-
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immuno-suppressive properties
-
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis
-
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation
-
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice
-
The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model
-
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain
-
The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus
-
Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice
-
The Influence of Cannabinoids on Generic Traits of Neurodegeneration
-
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
-
Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6
-
Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier
-
Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathway
-
Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation
-
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
-
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis
-
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis
-
Prospects for cannabinoid therapies in viral encephalitis
-
CB1 Cannabinoid Receptor Agonist Prevents NGF-Induced Sensitization of TRPV1 in Sensory Neurons
-
Anti-inflammatory effects of Cannabinoid 2 Receptor activation in endotoxin-induced uveitis
-
Cannabinoid receptor modulation of the endothelial cell inflammatory response
-
Cytokine release in sepsis
-
Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying CannabinoidMediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells
-
Reduces Formalin-Induced Neuropathic-Like Behaviour Through Spinal Glial/Microglial Phenotypical Changes in Mice
-
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoyl-ethanolamide in Models of Alzheimerâs Disease
-
New Insights in Mast Cell Modulation by Palmitoylethanolamide
-
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects
-
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut
-
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system
-
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models
-
Endocannabinoids: A unique opportunity to develop multitarget analgesics
-
Endocannabinoids: A unique opportunity to develop multitarget analgesics
-
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator
-
Cannabinoid CB2 receptors as novel target for inhibiting house dust mite induced allergic airway inflammation
-
Amyotrophic Lateral Sclerosis Treatment with Ultramicronized Palmitoylethanolamide: A Case Report
-
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis
-
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electro-acupuncture on experimental arthritis of the rat temporomandibular joint
-
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype
-
Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy
-
Cannabidiol in inflammatory bowel diseases: a brief overview
-
Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice
-
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice
-
Magnolol inhibits LPS-induced inflammatory response in uterine epithelial cells : magnolol inhibits LPS-induced inflammatory response
-
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract
-
Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuro-inflammation and apoptosis after neonatal ischemic brain damage
-
Endocannabinoids: a unique opportunity to develop multitarget analgesics
-
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model
-
New insights in mast cell modulation by palmitoylethanolamide
-
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma
-
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells
-
Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction
-
Inhibition of Fatty Acid binding proteins elevates brain anandamide levels and produces analgesia
-
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases
-
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling (SOCS)-3 in intestinal epithelium
-
CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat
-
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
-
Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function
-
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
-
Endocannabinoids and inflammatory response in periodontal ligament cells
-
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration
-
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2
-
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
-
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimerâs disease
-
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints
-
Cannabinoid receptor type-2 stimulation, blockade, and deletion alters the vascular inflammatory responses to traumatic brain injury
-
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal antiinflammatory agent
-
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors
-
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins
-
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain
-
Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation
-
Endocannabinoid signalling and the deteriorating brain
-
Chronic administration of Î9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute SIV infection of rhesus macaques
-
The cannabinoid CBâ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain
-
Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats
-
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats
-
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon Npalmitoyl-ethanolamine levels and counteracts murine colitis
-
Molecular Basis for the Improvement in Muscle Metaboreflex and Mechanoreflex Control in Exercise-Trained Humans with Chronic Heart Failure
-
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease
-
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models
-
Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ-Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain
-
Enhanced microglial activity in FAAH-/- animals
-
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005â2010
-
In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines
-
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury
-
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β
-
The endocannabinoid system: an emerging key player in inflammation
-
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia
-
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus
-
Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity
-
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor
-
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain
-
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis
-
Host Neuro- Immuno-Endocrine Responses In Periodontal Disease
-
Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation
-
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases
-
Cannabinoid 1 receptors in keratinocytes attenuate FITC-induced mouse atopic-like dermatitis
-
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands
-
Anti-atherosclerosis role of N-oleoylethanolamine in CB2
-
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor
-
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders
-
Cannabinoid receptor CB2 prevents development of heart failure in a murine model of pressure overload
-
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage
-
Increased oxidative stress enhances endocannabinoid tone
-
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice
-
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases
-
Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment
-
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells
-
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways
-
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation
-
Protective effect of palmitoylethanolamide, a naturally-occurring molecule, in a rat model of cystitis
-
Neuroinflammation as a possible link between cannabinoids and addiction
-
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?
-
Potential applications of marijuana and cannabinoids in medicine
-
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators
-
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation
-
Protective role of the cannabinoid receptor system in A2E-mediated photo-toxicity to retinal pigment epithelium (RPE) cells in an in-vitro model of age-related macular degeneration (AMD)
-
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005â2010
-
NONRETROGRADE ENDOCANNABINOID SIGNALING MODULATES RETINAL GANGLION CELL CALCIUM HOMEOSTASIS THROUGH THE TRPV1 CATION CHANNEL
-
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation
-
How Smoking Marijuana Might Be The Best Way To Prevent Alzheimerâs Disease
-
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain?
-
Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells
-
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo
-
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats
-
Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells
-
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
-
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells
-
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells
-
New horizons for newborn brain protection: enhancing endogenous neuroprotection
-
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation
-
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures
-
CB2R orchestrates fibrogenesis through regulation of inflammatory response during the repair of skeletal muscle contusion
-
Time-Dependent Protection of CB2 Receptor Agonist in Stroke
-
Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA
-
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity
-
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis
-
Expression Analysis of CB2-GFP BAC Transgenic Mice
-
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimerâs Disease
-
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
-
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice
-
GPR55 â a putative âtype 3â cannabinoid receptor in inflammation
-
Oxyradical Stress, Endocannabinoids, and Atherosclerosis
-
Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC)
-
Fever Is Mediated by Conversion of Endocannabinoid 2-Arachidonoylglycerol to Prostaglandin E2
-
Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner
-
Deletion of Monoglyceride Lipase in Astrocytes Attenuates Lipopolysaccharide-Induced Neuro-inflammation
-
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study
-
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study
-
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression, epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice
-
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression, epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice
-
HU-446 and HU-465, derivatives of the non-psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells
-
Nitric oxide secretion in human conjunctival fibroblasts is inhibited by alpha linolenic acid.
-
4â²-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation.
-
Î9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells
-
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
-
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium
-
Effects of Cannabinoids on T-cell Function and Resistance to Infection
-
Effects of Cannabinoids on T-cell Function and Resistance to Infection
-
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoylglycerol and arachidonoyl-ethanolamide, and their metabolites
-
Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol
-
Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury from SO2 Inhalation via PPARγ Pathway
-
Fatty acid amide hydrolase inhibitors: a patent review (2009-2014
-
Fatty acid amide hydrolase inhibitors: a patent review (2009- 2014
-
Polyunsaturated fatty acids and inflammation
-
Polyunsaturated fatty acids and inflammation
-
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents
-
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents
-
Distribution of Bioactive Lipid Mediators in Human Skin
-
Distribution of Bioactive Lipid Mediators in Human Skin.
-
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (click Full Text Links for
-
Cannabinoid receptor-specific mechanisms to ameliorate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation
-
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids
-
Activation of cannabinoid receptor 2 attenuates synovitis and joint destruction in collagen-induced arthritis
-
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
-
Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model
-
Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling
-
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
-
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
-
The endocannabinoid system and its therapeutic implications in rheumatoid arthritis
-
Minocycline Attenuates Neonatal Germinal-Matrix-Hemorrhage-Induced Neuroinflammation and Brain Edema by Activating Cannabinoid Receptor 2
-
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinsonâs disease
-
Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinsonâs disease
-
The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats
-
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity
-
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?
-
Downstream effects of endocannabinoid on blood cells: implications for health and disease
-
Lipopolysaccharide-induced murine embryonic resorption involves changes in endocannabinoid profiling and alters progesterone secretion and inflammatory response by a CB1-mediated fashion
-
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution
-
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment
-
Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis
-
ical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model
-
Impact of a synthetic cannabinoid (CP-47,497-C8) on protein expression in human cells: evidence for induction of inflammation and DNA damage
-
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists As Potential Treatment for Inflammatory Kidney Diseases
-
Pro-inflammatory obesity in aged cannabinoid-2 receptor deficient mice
-
Fatty acids, endocannabinoids and inflammation
-
Endocannabinoid regulation of amyloid-induced neuroinflammation
-
Lipopolysaccharide Suppresses Carboxylesterase 2g Activity and 2-Arachidonylglycerol Hydrolysis: A Possible Mechanism to Regulate Inflammation
-
Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusionin the iridial microvasculature during systemic inflammation
-
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis
-
Deletion of G-protein coupled receptor 55 promotes obesity by reducing physical activity
-
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats
-
A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation
-
Î9-Tetrahydrocannabinol (Î9-THC) Promotes Neuroimmune-Modulatory MicroRNA Profile in Striatum of Simian Immunodeficiency Virus (SIV)-Infected Macaques
-
Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants
-
Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis
-
Endocannabinoids â at the crossroads between the gut microbiota and host metabolism
-
Cell type-specific modulation of lipid mediatorâs formation in murine adipose tissue by omega-3 fatty acids
-
Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimerâs disease mouse model
-
Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults
-
Lipid signaling in adipose tissue: Connecting inflammation & metabolism
-
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model
-
Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoEDeficient Mice
-
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice
-
Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta
-
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2
-
Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model
-
Vaccenic acid suppresses intestinal inflammation by increasing the endocannabinoid anandamide and non-cannabinoid signaling molecules in a rat model of the metabolic syndrome
-
Differential Regulation of Eicosanoid and Endocannabinoid Production by Inflammatory Mediators in Human Choriodecidua
-
Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells
-
New insights into the yin and yang of the endocannabinoid system in health and disease
-
CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury
-
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing Remitting Multiple Sclerosis
-
Editorial: Lung macrophages high on cannabinoids: jamming PAMs and taming TAMs?
-
Protective Action of Anandamide and its COX-2 Metabolite against L-Homocysteine induced NLRP3 Inflammasome Activation and Injury in Podocytes
-
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
-
Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids
-
CB2 Cannabinoid Receptor As Potential Target against Alzheimerâs Disease
-
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
-
Expression of the endocannabinoid receptors in human fascial tissue
-
The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway
-
The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets
-
Immunohistochemical analysis of cannabinoid receptor 1 expression in steatotic rat livers
-
Cannabinoid receptor 2 modulates susceptibility to experimental cerebral malaria through a CCL17-dependent mechanism
-
Spontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin Treatment
-
Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation.
-
Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain
-
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature
-
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats
-
The CB2 receptor and its role as a regulator of inflammation
-
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK
-
Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats
-
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist
-
Longitudinal examination of the intestinal lamina propria cellular compartment of SIVinfected rhesus macaques provides broader and deeper insights into the link between aberrant microRNA expression and persistent immune activation
-
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse
-
Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages
-
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis
-
Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation
-
Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation
-
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation. (click âMolecular Medicineâ for
-
Getting into the weed: the role of the endocannabinoid system in the brain-gut axis
-
G protein-coupled receptor 18: A potential role for endocannabinoid signalling in metabolic dysfunction
-
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats
-
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions
-
β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats
-
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell Permeability through an Arachidonic Acid Metabolite
-
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives
-
Endocannabinoids in Cerebrovascular Regulation
-
Anti-Inflammatory and Osteoprotective Effects of Cannabinoid-2 Receptor Agonist Hu- 308 in a Rat Model of Lipopolysaccharide-Induced Periodontitis
-
Cannabinoids for the Treatment of Schizophrenia: An Overview
-
Stimulation of cannabinoid CB1 receptors prevents nerve-mediated airway hyperreactivity in NGF-induced inflammation in mouse airways
-
Role of cannabinoids in gastrointestinal mucosal defense and inflammation
-
Endocannabinoid concentrations in hair are associated with PTSD symptom severity
-
N-acyl ethanolamide and eicosanoid involvement in irritant dermatitis
-
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices
-
Marijuana-derived Î-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation
-
Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed type hypersensitivity
-
2-pentadecyl-2-oxazoline: identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation
-
Anandamide and its metabolites: what are their roles in the kidney?
-
Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats
-
Mustard vesicants alter expression of the endocannabinoid system in mouse skin
-
Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor
-
Expression analysis of cannabinoid receptors 1 and 2 in B cells during pregnancy and their role on cytokine production
-
Cannabis for refractory psoriasis-high hopes for a novel treatment and a literature review
-
Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability
-
MEDICAL CANNABIS
-
Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages
-
The effect of cannabinoids on dinitrofluorobenzene-induced experimental asthma in mice
-
Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1/M2 polarization through the cAMP/PKA pathway in an experimental GMH rat model
-
Pharmacological activation of cannabinoid 2 receptor attenuates inflammation, fibrogenesis, and promotes re-epithelialization during skin wound healing
-
N-Oleoylethanolamine reduces inflammatory cytokines and adhesion molecules in TNF- α-induced human umbilical vein endothelial cells by activating CB2 and PPAR-α
-
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammationdriven rat models of Parkinsonâs disease
-
Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation
-
Docosahexaenoic acid attenuates in endocannabinoid synthesis in RAW 264.7 macrophages activated with benzo(a)pyrene and lipopolysaccharide
-
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response
-
LINOLEIC ACID AND THE PATHOGENESIS OF OBESITY
-
Microglia activation states and cannabinoid system: Therapeutic implications
-
The cannabinoid 2 receptor agonist β-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration
-
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling
-
Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia
-
Cannabinoids, inflammation, and fibrosis
-
Expression of the Endocannabinoid Receptor 1 in Human Stroke: An Autoptic Study
-
Heterologous Regulation of the Cannabinoid Type 1 Receptor by Angiotensin II in Astrocytes of Spontaneously Hypertensive Rats
-
The gastrointestinal tract â a central organ of cannabinoid signaling in health and disease
-
Endocannabinoids inhibit neurogenic inflammation in murine joints by a non-canonical cannabinoid receptor mechanism
-
Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy
-
Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα
-
Î9-Tetrahydrocannabinol Reverses TNFα-induced Increase in Airway Epithelial Cell Permeability through CB2 Receptors
-
N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism
-
Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23âIL-17 signalling in macrophages
-
Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes
-
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis
-
Activation of Cannabinoid Receptor 2 Attenuates Mechanical Allodynia and Neuroinflammatory Responses in a Chronic Post-Ischemic Pain Model of Complex Regional Pain Syndrome Type I in Rats
-
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis
-
Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism
-
Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and Nacylethanolamine acid amidase inhibitors
-
Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes
-
Oxyradical Stress Increases the Biosynthesis of 2-Arachidonoylglycerol: Involvement of NADPH Oxidase
-
Cannabinoids, inflammation, and fibrosis
-
Medical Marijuana: Just the Beginning of a Long, Strange Trip?
-
Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases
-
Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine
-
The combination of β-caryophyllene, baicalin and catechin synergistically suppresses the proliferation and promotes the death of RAW267.4 macrophages in vitro
-
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
-
CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma
-
The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis
-
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons
-
WWL70 attenuates PGE2 production derived from 2-arachidonoylglycerol in microglia by ABHD6-independent mechanism
-
Targeting Cutaneous Cannabinoid Signaling in Inflammation â A âHighâ-way to Heal?
-
Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain
-
Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion
-
Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice
-
Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation
-
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain
-
Serum endocannabinoids and N-acyl ethanolamines and the influence of simulated solar UVR exposure in humans in vivo
-
N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation
INTERACTIONS WITH OTHER DRUGS (163)
-
THC Prevents MDMA Neurotoxicity in Mice
-
Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects
-
Adolescent cannabis use increases risk for cocaine-induced paranoia
-
Opioid antagonism enhances marijuanaâs effects in heavy marijuana smokers
-
Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users
-
Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CBâ cannabinoid receptors
-
Probable Interaction Between Warfarin and Marijuana Smoking
-
Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative / Nitrosative Stress, Inflammation, and Cell Death
-
The safety of modafinil in combination with oral â9-tetrahydrocannabinol in humans
-
Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol)
-
Inhibition of monoacylglycerol lipase (MAGL) attenuates NSAID-induced gastric hemorrhages in mice
-
Pretreatment with Î9-tetrahydrocannabinol (THC) increases cocaine-stimulated activity in adolescent but not adult male rats
-
Combined effects of THC and caffeine on working memory in rats
-
Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Î9-THC administration into the medial prefrontal cortex
-
Cannabinoid system and cyclooxygenases inhibitors
-
Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine
-
Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers
-
A combined preclinical therapy of cannabinoids and temozolomide against glioma
-
Efavirenz interference in urine screening immunoassays for tetrahydrocannabinol
-
Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity
-
Possible involvement of the endocannabinoid system in memory modulation effect of general anesthetics
-
Role of GLT-1 transporter activation in prevention of cannabinoid tolerance by the betalactam antibiotic, ceftriaxone, in mice
-
Cannabinoid-opioid interaction in chronic pain
-
Cannabidiol potentiates Î(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats
-
The G protein-coupled cannabinoid-1 (CB(1)) receptor of mammalian brain: Inhibition by phthalate esters in vitro
-
The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects
-
THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats
-
Pharmacokinetics of a combination of Î9-tetrahydro-cannabinol and celecoxib in a porcine model of hemorrhagic shock
-
Low-volume binary drug therapy for the treatment of hypovolemia
-
β-adrenergic Antagonists, Carbonic Anhydrase Inhibitors And α2-agonists Reduce The Effects Of Cannabinoids In A Rat Glaucoma Model
-
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews
-
Synergistic interaction of pregabalin with the synthetic cannabinoid WIN 55,212-2 mesylate in the hot-plate test in mice: an isobolographic analysis
-
Changes of Blood Endocannabinoids during Anaesthesia: a Special Case for Fatty Acid Amide Hydrolase Inhibition by Propofol?
-
Î9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys
-
Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats
-
The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids
-
Effects of ethanol, Î(9)-tetrahydrocannabinol, or their combination on object recognition memory and object preference in adolescent and adult male rats
-
β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner
-
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Î 9-Tetrahydro-cannabinol and Cannabidiol in Rodent Models of Schizophrenia
-
Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation
-
Effect of ACEA-a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model
-
Effects of dronabinol on morphine-induced dopamine-related behavioral effects in animals
-
Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain
-
Interactions between mu opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration
-
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report
-
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers
-
Dual Inhibition of Endocannabinoid Catabolic Enzymes Produces Enhanced Anti-Withdrawal Effects in Morphine-Dependent Mice
-
Dissociation of the Pharmacological Effects of THC by mTOR Blockade
-
AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced Cognitive Deficit
-
Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users
-
In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist
-
Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy
-
Prior Exposure to THC Increases the Addictive Effects of Nicotine in Rats
-
Efavirenz does not cause false-positive urine cannabis test in HIV-infected patients on Highly Active Anti-Retroviral Therapy
-
Acute Î9-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice
-
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2
-
Acute Psychosis Associated with Recreational Use of Benzofuran 6-(2-Aminopropyl)Benzofuran (6-APB) and Cannabis
-
Impact of Cannabis Use during Stabilization on Methadone Maintenance Treatment
-
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
-
Does olanzapine inhibit the psychomimetic effects of Î9-tetrahydrocannabinol?
-
Cannabis and Cigarettes
-
Interactions between mu opioid receptor agonists and cannabinoid receptor agonists CP55940 and WIN55212-2 in rhesus monkeys: evaluation of treatment- and abuserelated effects
-
Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference
-
Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Î9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva)
-
Activation of type-2 cannabinoid receptor inhibits neuroprotective and anti-inflammatory actions of glucocorticoid receptor α: when one is better than two
-
Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus
-
Effects of WIN 55,212-2 (a non-selective cannabinoid CB1 and CB 2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz psychomotor seizure model
-
Cyclosporine and Herbal Supplement Interactions
-
Updates on the Clinical Evidenced Herb-Warfarin Interactions
-
Î9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity
-
Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results
-
Pregnenolone can protect the brain from cannabis intoxication
-
An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults
-
Impact of efficacy at the mu opioid receptor on antinociceptive effects of combinations of mu opioid receptor agonists and cannabinoid receptor agonists
-
Î9-THC exposure attenuates aversive effects and reveals appetitive effects of K2 /âSpiceâ constituent JWH-018 in mice
-
Acute administration of Î9 tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice
-
Cannabis Withdrawal in Patients With and Without Opioid Dependence
-
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors
-
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats
-
Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute d-amphetamine
-
Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice
-
Effects of opioids and cannabinoids during chronic morphine treatment in rhesus monkeys
-
Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice
-
Experience of adjunctive cannabis use for chronic non-cancer pain: Findings from the Pain and Opioids IN Treatment (POINT) study
-
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS
-
THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS PROGRAM
-
RESOLUTION OF SEIZURES AND NORMALIZATION OF EEG AFTER INITIATION OF CBD IN A PATIENT WITH DOOSE SYNDROME
-
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use
-
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol
-
Interaction between Cannabinoid Compounds and Capsazepine in Protection against Acute Pentylenetetrazole-induced Seizure in Mice
-
Combined effects of marijuana and nicotine on memory performance and hippocampal volume
-
Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward
-
Combined effects of marijuana and nicotine on memory performance and hippocampal volume
-
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2
-
13-Year-Old Girl With Recurrent, Episodic, Persistent Vomiting: Out of the Pot and Into the Fire
-
Cigarette smoking may modify the association between cannabis use and adiposity in males
-
Novel associations between FAAH genetic variants and postoperative central opioid related adverse effects
-
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
-
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone
-
Cannabinoids and Epilepsy
-
The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats
-
The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats (link to
-
Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates
-
Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice
-
Anaesthetic consideration in a cannabis addict
-
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine
-
Morphine-induced locomotor sensitization produces structural plasticity in the mesocorticolimbic system dependent on CB1-R activity
-
Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys
-
Do Cannabinoid Receptor Agonists Have A Role In The Intensive Care Unit? ⦠Totally Dude!
-
Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships
-
Variations in Cannabis Use Level and Correlates in Opiate-Users on Methadone Maintenance Treatment: A French Prospective Study
-
Clinical pharmacology of medical cannabinoids in chronic pain
-
Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocananbinol in humans discriminating [INCREMENT]9-tetrahydrocananbinol
-
Genetic inactivation and prolonged pharmacologic inhibition of monoacylglycerol lipase have opposite effects on anesthetic sensitivity to propofol
-
Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11
-
Polypharmacology Shakes Hands with Complex Aetiopathology
-
Khat (Catha edulis F) and cannabinoids: Parallel and contrasting behavioral effects in preclinical and clinical studies
-
Ghrelin and endocannabinoids participation in morphine-induced effects in the rat nucleus accumbens
-
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
-
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats
-
Influence of arachidonylâ2â²âchloroethylamide, a selective cannabinoid CB1 receptor agonist, on the anticonvulsant and acute sideâeffect potentials of clobazam, lacosamide, and pregabalin in the maximal electroshockâinduced seizure model and chimney test in mice
-
Analysis of the anti-allodynic effects of combination of a synthetic cannabinoid and a selective noradrenaline re-uptake inhibitor in nerve injury-induced neuropathic mice
-
Combined Treatment with Morphine and Î9-Tetrahydrocannibinol (THC) in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal
-
Is cannabis use associated with less opioid use among people who inject drugs?
-
Nicotine Changes Marijuanaâs Effect on the Brain
-
Cannabinoids for pediatric epilepsy? Up in smoke or real science?
-
Effects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait
-
A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder
-
Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl
-
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis
-
Effect of interaction between acute administration of morphine and cannabinoid compounds on spontaneous excitatory and inhibitory postsynaptic currents of magnocellular neurons of supraoptic nucleus
-
High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana
-
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues
-
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats
-
Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration
-
The selective monoacylglycerol lipase inhibitor MJN110 produces opioid sparing effects in a mouse neuropathic pain model
-
Behavioral Characterization of Kappa Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats (link to
-
Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive Behavior during Forced Abstinence from Alcohol Drinking
-
The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders
-
Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens
-
Combined treatment with morphine and Î9-tetrahydrocannibinol (THC) in rhesus monkeys: antinociceptive tolerance and withdrawal
-
Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy
-
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain: A Prospective Open-label Study
-
Medical cannabis associated with decreased opiate medication use in retrospective crosssectional survey of chronic pain patients
-
Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products
-
Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages
-
Opioid and cannabinoid synergy in a mouse neuropathic pain model.
-
Marijuana Use and Its Effects in Pregnancy
-
Substitution and Complementarity of Alcohol and Cannabis: A Review of the Literature
-
Co-occurrent cannabis and tobacco uses: Clinical knowledge and therapeutic prospects
-
Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids
-
Basolateral amygdala CB1 cannabinoid receptors are involved in cross state-dependent memory retrieval between morphine and ethanol
-
Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?
-
Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia
-
Behavioral evidence for the interaction between cannabinoids and Catha edulis F. (Khat) in mice
-
Marijuana and tobacco co-administration in blunts, spliffs, and mulled cigarettes: A systematic literature review
-
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl- 2â²-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice
-
Interactive effects of AM251 and baclofen on synaptic plasticity in the rat dentate gyrus.
-
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl- 2â²-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice
-
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice
-
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function
-
Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites
-
Interactions between cannabidiol and Î9-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the mesolimbic pathway
INTRAVENTRICULAR HEMORRHAGE (1)
IQ/MEMORY/COGNITIVE EFFECTS (312)
-
Influence of cannabis use trajectories, grade repetition and family background on the school-dropout rate at the age of 17 years in France
-
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation
-
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome
-
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
-
The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample
-
Evaluating the effect of aquatic extraction of Cannabis sativa seed on spatial memory consolidation
-
Evaluating the effect of Cannabis sativa seed extraction on memory
-
Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid
-
Gender moderates the impact of stereotype threat on cognitive function in cannabis users
-
An Evidence Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions
-
AM251, cannabinoids receptors ligand, improves recognition memory in rats
-
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neuro-degeneration and therapeutic interventions
-
Combined effects of THC and caffeine on working memory in rats
-
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users
-
Sex, drugs, and cognition: effects of marijuana
-
Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Î9-THC administration into the medial prefrontal cortex
-
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice
-
Intelligence across childhood in relation to illegal drug use in adulthood: 1970 British Cohort Study
-
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition
-
Effects of endocannabinoid system modulation on cognitive and emotional behavior
-
Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Î9-tetrahydrocannabinol on spatial memory
-
Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus
-
Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress
-
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors
-
Propofol Enhances Memory Formation via an Interaction with the Endocannabinoid System
-
Fish oil promotes survival and protects against cognitive decline in severely under-nourished mice by normalizing satiety signals
-
Effects of Chronic Marijuana Use on Brain Activity During Monetary Decision-Making
-
The dual neuroprotective-neurotoxic profile of cannabinoid drugs
-
Patent WO 2010012506 A1 â CANNABINOIDS FOR USE IN TREATING OR PREVENTING COGNITIVE IMPAIRMENT AND DEMENTIA
-
Possible involvement of the endocannabinoid system in memory modulation effect of general anesthetics
-
Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice
-
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
-
Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
-
4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway
-
Assessing topographical orientation skills in cannabis users
-
Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THClike Morris water maze deficits in mice
-
Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory
-
Extinction learning of rewards in the rat: is there a role for CB1 receptors?
-
An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimerâs disease
-
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention?
-
Intelligence quotient in childhood and the risk of illegal drug use in middle-age: the 1958 National Child Development Survey
-
The endocannabinoid system: a key modulator of emotions and cognition
-
Endocannabinoids in nervous system health and disease: the big picture in a nutshell
-
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids
-
Involvement of the endocannabinoid system in reward processing in the human brain
-
Cannabis Responsive Head Injury Induced Mutiple Disabilities: A Case Report
-
The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-β and in the cortex of aged rats
-
Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Î(9)-THC in Humans
-
Adolescent Exposure of JWH-018 âSpiceâ Produces Subtle Effects on Learning and Memory Performance in Adulthood
-
The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users
-
Cannabinoids and value-based decision making: implications for neurodegenerative disorders
-
Functional connectivity in brain networks underlying cognitive control in chronic cannabis users
-
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis
-
Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD
-
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuro-inflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models
-
Effects of ethanol, Î(9)-tetrahydrocannabinol, or their combination on object recognition memory and object preference in adolescent and adult male rats
-
Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers
-
Adolescent Exposure of JWH-018 âSpiceâ Produces Subtle Effects on Learning and Memory Performance in Adulthood
-
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
-
Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis
-
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimerâs disease via regulation of β-secretase activity
-
Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it
-
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids
-
Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo
-
Neurocognitive functioning and cannabis use in schizophrenia
-
Pharmacological effects of cannabinoids on the reference and working memory functions in mice
-
Long-term behavioral and biochemical effects of an ultra-low dose of Î(9)-tetrahydrocannabinol (THC): neuroprotection and ERK signaling
-
Effects of Î9-Tetrahydrocannabinol Administration on Human Encoding and Recall Memory Function: A Pharmacological fMRI Study
-
A biophysical model of endocannabinoid-mediated short term depression in hippocampal inhibition
-
Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors
-
Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans
-
Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users
-
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis
-
An investigation into âtwo hitâ effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in mice
-
Effects of magnolol on impairment of learning and memory abilities induced by scopolamine in mice
-
Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status
-
A role for the endocannabinoid system in exercise-induced spatial memory enhancement in mice
-
Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction
-
COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users
-
AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced Cognitive Deficit
-
Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory
-
Novelty-Induced Emotional Arousal Modulates Cannabinoid Effects on Recognition Memory and Adrenocortical Activity
-
Dissociation of the Pharmacological Effects of THC by mTOR Blockade
-
Impact of ADHD and cannabis use on executive functioning in young adults
-
Impulsivity, Variation in the Cannabinoid Receptor (CNR1) and Fatty Acid Amide, Hydrolase (FAAH) Genes, and Marijuana-Related Problems
-
Cannabidiol attenuates deficits of visuo-spatial associative memory induced by Î9-tetrahydrocannabinol
-
Effects of a novel CB1 agonist on visual attention in male rats: Role of strategy and expectancy in task accuracy
-
CB1 Receptor-Mediated Signaling Underlies the Hippocampal Synaptic, Learning and Memory Deficits Following Treatment with JWH-081, a New Component of Spice/K2 Preparations
-
Differential effects of the cannabinoid agonist WIN55,212-2 on delay and trace eyeblink conditioning
-
CB1 receptor signaling regulates social anxiety and memory
-
Performance in working memory and attentional control is associated with the rs2180619 SNP in the CNR1 gene
-
The neuroprotective effects of cocoa flavanol and its influence on cognitive performance
-
Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency
-
Developmentally-induced hypothyroidism alters the expression of Egr-1 and Arc genes and the sensitivity to cannabinoid agonists in the hippocampus. Possible implications for memory and learning
-
Effect of cannabinoid CB2 receptor agonism on learning and memory in a mouse model of photothrombosis
-
Cannabidiol attenuates the long lasting cognitive deficits and anxiogenic-like behaviors promoted by murine cerebral malaria
-
Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors
-
Cannabinoid receptor 1 deficiency in a mouse model of Alzheimerâs disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition
-
Cannabis abuse is associated with better emotional memory in schizophrenia: A functional magnetic resonance imaging study
-
Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats
-
Erratum to: Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats
-
The endocannabinoid system: An emotional buffer in the modulation of memory function
-
The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice
-
Chronic ethanol alters network activity and endocannabinoid signaling in the prefrontal cortex
-
Monoacylglycerol Lipase Inhibitor JZL184 Improves Behavior and Neural Properties in Ts65Dn Mice, a Model of Down Syndrome
-
Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disorders
-
Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates
-
An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults
-
Neurocognition in college-aged daily marijuana users
-
Synaptic and Cognitive Improvements by Inhibition of 2-AG Metabolism Are through Up-regulation of MicroRNA-188-3p in a Mouse Model of Alzheimerâs Disease
-
Impaired Fear Memory Specificity Associated with Deficient EndocannabinoidDependent Long-Term Plasticity
-
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area
-
β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1-Dependent Synaptic Disinhibition
-
Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferator-activated Receptor β/δ (PPARβ/δ) in the Brain
-
Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses
-
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
-
Elevation of Endogenous Anandamide Impairs LTP, Learning and Memory through CB1 Receptor Signaling in Mice
-
Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training
-
Amyrin Attenuates Scopolamine-Induced Cognitive Impairment in Mice
-
The Impact of a Motivational Statement and Age of Cannabis Use Onset on Neuro-psychological Test Performance
-
Functional Genetic Variation of the Cannabinoid Receptor 1 and Cannabis use Interact on Prefrontal Connectivity and Related Working Memory Behavior
-
Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans
-
Endocannabinoid Signaling within the Basolateral Amygdala Integrates Multiple Stress Hormone Effects on Memory Consolidation
-
Multifractal analysis of information processing in hippocampal neural ensembles during working memory under Î9-tetrahydrocannabinol administration
-
Acute administration of THC impairs spatial but not associative memory function in zebrafish
-
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection
-
Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia
-
WIN55212-2 impairs non-associative, recognition and spatial memory in rats via CB1 receptor stimulation
-
CB1 receptor antagonism in the granular insular cortex or somatosensory area facilitates consolidation of object recognition memory
-
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders
-
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ÎE9 Mouse Model of Alzheimerâs Disease
-
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage
-
Impact of Stress on Prefrontal Glutamatergic, Monoaminergic and Cannabinoid Systems
-
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice
-
Genetic variability in the human cannabinoid receptor 1 is associated with resting state EEG theta power in humans
-
Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors
-
Systemic or intra-amygdala infusion of an endocannabinoid CB1 receptor antagonist AM251 blocked propofol-induced anterograde amnesia
-
CP55,940 attenuates spatial memory retrieval in mice
-
Activation of cannabinoid system in anterior cingulate cortex and orbitofrontal cortex modulates cost-benefit decision making
-
Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimerâs disease transgenic mice
-
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1âE9 mice
-
Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice
-
Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls
-
Augmented Inhibition from Cannabinoid-Sensitive Interneurons Diminishes CA1 Output after Traumatic Brain Injury
-
Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189
-
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit
-
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms
-
Effects of high-fructose diets on central appetite signaling and cognitive function
-
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents
-
Task-specific enhancement of hippocampus-dependent learning in mice deficient in monoacylglycerol lipase, the major hydrolyzing enzyme of the endocannabinoid 2-arachidonoylglycerol
-
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors
-
Hormonal status and age differentially affect tolerance to the disruptive effects of delta-9-tetrahydrocannabinol (Î(9)-THC) on learning in female rats
-
Cannabis and psychopathology: The meandering journey of the last decade
-
Homeostatic regulation of brain functions by endocannabinoid signaling
-
Combined effects of marijuana and nicotine on memory performance and hippocampal volume
-
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimerâs Disease
-
The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, doubleblind, crossover pilot trial
-
Perinatal asphyxia results in altered expression of the hippocampal acylethanol-amide/endocannabinoid signaling system associated to memory impairments in post-weaned rats
-
The effect of BLA GABA(A) receptors in anxiolytic-like effect and aversive memory deficit induced by ACPA
-
Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex
-
Biased Type 1 Cannabinoid Receptor Signalling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease
-
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users
-
Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence
-
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes
-
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain
-
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain
-
Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats
-
Mechanisms of stress in the brain
-
Mechanisms of stress in the brain
-
Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Î9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences
-
Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies
-
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice
-
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice
-
Habenular CB1 Receptors Control the Expression of Aversive Memories
-
The involvement of medial septum 5-HT1 and 5-HT2 receptors on ACPA-induced memory consolidation deficit: Possible role of TRPC3, TRPC6 and TRPV2
-
The cannabinoid system in the retrosplenial cortex modulates fear memory consolidation, reconsolidation, and extinction
-
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drugâs harm to children and adults, but the scientific evidence is seldom clear-cut
-
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of Cerebral Malaria
-
Modulation of the effects of the cannabinoid agonist, ACPA, on spatial and non-spatial novelty detection in mice by dopamine D1 receptor drugs infused into the basolateral amygdala
-
Involvement of the serotonergic system of the ventral hippocampus (CA3) on amnesia induced by ACPA in mice
-
Effects of cannabinoid and glutamate receptor antagonists and their interactions on learning and memory in male rats
-
Intraperirhinal cortex administration of the synthetic cannabinoid, HU210, disrupts object recognition memory in rats
-
The potential of inhibitors of endocannabinoid metabolism as anxiolytic and anti-depressive drugs-A practical view
-
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling
-
Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats
-
The effects of chronic marijuana use on circadian entrainment
-
The dual effect of CA1 NMDA receptor modulation on ACPA-induced amnesia in stepdown passive avoidance learning task
-
The interactive role of cannabinoid and vanilloid systems in hippocampal synaptic plasticity in rats
-
Cannabinoid functions in the amygdala contribute to conditioned fear memory in streptozotocin-induced diabetic mice: interaction with glutamatergic functions
-
Astroglial type-1 cannabinoid receptors (CB1): A new player in the tripartite synapse
-
Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome
-
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment
-
The influence of cannabinoids on learning and memory processes of the dorsal striatum
-
Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)
-
Inhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female rats
-
No additive effect of cannabis on cognition in schizophrenia
-
Fatty acid amide hydrolase inhibitor URB597 prevented tolerance and cognitive deficits induced by chronic morphine administration in rats
-
Cannabinoids and Glucocorticoids in the Basolateral Amygdala Modulate HippocampalAccumbens Plasticity after Stress
-
Blockade of GPR55 in the dorsolateral striatum impairs performance of rats in a T-maze paradigm
-
Effect of nucleus accumbens shell 5-HT4 receptors on the impairment of ACPA-induced emotional memory consolidation in male Wistar rats
-
Providing a food reward reduces inhibitory avoidance learning in zebrafish
-
Enhanced Glutamatergic Synaptic Plasticity in the Hippocampal CA1 Field of Food Restricted Rats: Involvement of CB1 Receptors
-
Anandamide mediates cognitive judgement bias in rats
-
GABAA receptors in the central amygdala are involved in memory retention deficits induced by cannabinoids in rats
-
Effect of combined doses of Î9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague-Dawley) models of conditioned gaping
-
N-Palmitoyl serotonin alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of BDNF and p-CREB in mice
-
The interactive role of CB1 and GABAB receptors in hippocampal synaptic plasticity in rats
-
Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis
-
Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus
-
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience
-
Involvement of the infralimbic cortex and CA1 hippocampal area in reconsolidation of a contextual fear memory through CB1 receptors: effects of CP55,940
-
Synergistic effect between prelimbic 5-HT3 and CB1 receptors on memory consolidation deficit in adult male Sprague-Dawley rats: an isobologram analysis
-
Stress and memory: A selective review on recent developments in the understanding of stress hormone effects on memory and their clinical relevance
-
CB1 receptors in the formation of the different phases of memory-related processes in the inhibitory avoidance test in mice
-
Combined effects of HIV and marijuana use on neurocognitive functioning and immune status
-
Endocannabinoid signaling integrates multiple stress hormone effects on memory
-
Effects of Synthetic Cannabinoid JWH-018 and Phytocannabinoid Î9-THC on Learning and Memory in Mice
-
Ultra-low doses of tetrahydrocannabinol contribute to the survival of newly-born cells in the dentate gyrus of adult rats
-
Changes Marijuanaâs Effect on the Brain
-
Cannabinoid Receptors May Control Aversive Memories
-
Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study
-
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands
-
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory
-
Comparisons of Î9-tetrahydrocannabinol and Anandamide on a Battery of Cognition related Behavior in Nonhuman Primates
-
GABA and Endocannabinoids Mediate Depotentiation of Schaffer Collateral Synapses Induced by Stimulation of Temperoammonic Inputs
-
NO2 inhalation promotes Alzheimerâs disease-like progression: cyclooxygenase-2- derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted medication
-
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood
-
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction
-
Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
-
Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History
-
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats
-
Marijuana â How Safe is it Really?
-
Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males
-
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood
-
Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies
-
Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats
-
Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model
-
Endocannabinoid signaling in social functioning: an RDoC perspective
-
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function
-
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processesâa Short Review
-
Paracetamol sharpens reflection and spatial memory: a double-blind randomized controlled study in healthy volunteers
-
DDDT Ontogeny of sensorimotor gating and short-term memory processing throughout the adolescent period in rats
-
Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction
-
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system (click âFull Text Linksâ to
-
Synthetic Cannabinoid-Induced Immunosuppression Augments Cerebellar Dysfunction in Tetanus-Toxin Treated Mice
-
Should we care about sativex-induced neurobehavioral effects? A 6-month follow-up study
-
Î9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats
-
Ovariectomy Alters Gene Expression of the Hippocampal Formation in Middle-Aged Rats
-
Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV- adults.
-
Harvesting Benefits from Cannabinoids
-
Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons
-
Impaired cued and spatial learning performance and altered cannabinoid CB1 receptor functionality in the substantia nigra in a rat model of diabetic neuropathy
-
Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis
-
Facilitatory effect of AM281 on recognition memory in rats
-
Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats
-
Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimerâs Disease and Mild Cognitive Impairment
-
Interplay between serotonin and cannabinoid function in the amygdala in fear conditioning
-
Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimerâs Disease but Plays a Minor Role in the Therapeutic Properties of a CannabisBased Medicine
-
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices
-
Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use
-
Keep off the grass? Cannabis, cognition and addiction
-
Because difficulty is not the same for everyone: the impact of complexity in working memory is associated with cannabinoid 1 receptor genetic variation in young adults
-
Comorbid Cannabis and Tobacco Use in Adolescents and Adults
-
Neural mechanisms of sensitivity to peer information in young adult cannabis users
-
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimerâs disease
-
Activation of endocannabinoid system in the rat basolateral amygdala improved scopolamine-induced memory consolidation impairment
-
Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use
-
Activation of cannabinoid CB1 receptors in the ventral hippocampus improved stressinduced amnesia in rat
-
Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor
-
Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats
-
Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH- 018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence
-
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders
-
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models
-
Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVDhemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice
-
The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings
-
Cannabinoid Receptor 1 (CNR1) Gene Variant Moderates Neural Index of Cognitive Disruption during Nicotine Withdrawal
-
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling
-
Endocannabinoid signaling and memory dynamics: a synaptic perspective
-
Behavioral evidence for the interaction between cannabinoids and Catha edulis F. (Khat) in mice
-
Adolescent cannabis use: What is the evidence for functional brain alteration?
-
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation
-
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention
-
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety
-
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model
-
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit
-
Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related Behaviors and Working Memory
-
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia
-
Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia
-
Cannabis for Cognitive Enhancement as a New Coping Strategy? Results From a Survey of Students at Four Universities in Germany
-
Abnormal white matter integrity in synthetic cannabinoid users
-
Interaction between hippocampal serotonin and cannabinoid systems in reactivity to spatial and object novelty detection
-
The use of the Emotional â Object Recognition as an assay to assess learning and memory associated to an aversive stimulus in rodents
-
CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal
-
Cannabinoid Modulation of Memory Consolidation within the Cerebellum
-
A cannabinoid link between mitochondria and memory
-
A longitudinal examination of the relationship between cannabis use and cognitive function in mid-life adults
-
Alcohol, tobacco and cannabis use: Do students with mild-intellectual disability mimic students in the general population?
-
Neuromodulatory effects of the dorsal hippocampal endocannabinoid system in dextromethorphan/morphine-induced amnesia
-
The effects of cannabis use on salience attribution: a systematic review
-
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
-
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
-
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function
-
Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA
-
URB597 improves cognitive impairment induced by chronic cerebral hypoperfusion by inhibiting mTOR-dependent autophagy
-
Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls
-
Marijuana Could Help Treat Drug Addiction and Mental Health Problems
-
Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA
-
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults
-
(S)Pot on Mitochondria: Cannabinoids Disrupt Cellular Respiration to Limit Neuronal Activity
-
Effects of cannabinoid and vanilloid receptor agonists and their interaction on learning and memory in rats
-
The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal-amygdala-insular circuit
-
Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration
